Opioid Use Disorder Market Future Trends, Insights, Top Players Analysis And Forecast To 2030 |Grand View Research, Inc.Posted by Mrudula Anil Karmarkar on September 5th, 2024 San Francisco, 05 September 2024: The Report Opioid Use Disorder Market Size, Share & Trends Analysis Report By Drug (Naltrexone, Buprenorphine, Methadone), By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030 The global opioid use disorder market size is expected to reach USD 10.25 billion by 2030, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 11.65% from 2024 to 2030. Rising opioid epidemic and growing government initiatives to combat the crisis are likely to propel market growth. In addition, growing commercialization of novel products is further anticipated to drive growth. In 2018, about 2.9 million people aged 15 or above were suffering from this disorder in the U.S. In 2016, according to the National Survey on Drug Use and Health (NSDUH), in the U.S., around 11.5 million people had abused prescription opioids in the earlier year and more than 2 million were addicted to prescribed drugs. According to the CDC, around 130 Americans die every day due to the opioid overdose and the U.S. government has designated this as a public health emergency.For patients wanting to overcome their addiction, adherence to a Medication-assisted Treatment (MAT) can reduce the withdrawal symptoms and cut the risk of death by half. Three U.S. FDA-approved MAT options are buprenorphine, methadone, and naltrexone. They are available in numerous dosages and formulations, with daily oral buprenorphine as the standard of care. To combat the opioid crisis, several measures have been undertaken in recent years. For instance, in 2016, CDC clinical practice guidelines for prescribing these drugs for chronic pain were issued and new American Society of Addiction Medicine (ASAM) National Practice Guidelines was adopted in 2015 to improve standard of care. Furthermore, in 2016, the U.S. FDA announced plans to overhaul its regulations for abuse-deterrent opioids, enhance safety labeling, and re-examine the risk-benefit paradigm of their use. The expansion of the market is driven by the rising rates of substance use disorders, growing government efforts to address the crisis, and increased awareness of opioid use disorder treatments. These factors are anticipated to significantly boost market growth over the forecast period, fostering innovation and improving access to addiction care solutions. Request sample report of Opioid Use Disorder Market@ https://www.grandviewresearch.com/industry-analysis/opioid-use-disorder-market/request/rs1 The rising incidence of substance use disorders is a major factor driving the market for medications targeting conditions like opioid use disorder. As more individuals experience substance use issues, the demand for effective treatments grows, shaping market trends and stimulating advancements in addiction medicine. The 2022 National Survey on Drug Use and Health (NSDUH), published by the Substance Abuse and Mental Health Services Administration (SAMHSA), offers extensive data on substance use and mental health trends in the U.S. According to the survey, 59.8% of individuals aged 12 or elder engaged in the use of tobacco, alcohol, or illicit drugs in 2022, with 70.3 million having used illicit drugs within the past year, and marijuana being the most frequently used. Additionally, 48.7 million people were reported to have a substance use disorder (SUD), encompassing both alcohol and drug use disorders. The survey also found that 23.1% of adults experienced mental illness, and 19.5% of adolescents had a major depressive episode. Opioid Use Disorder Market Report Highlights
Furthermore, increasing government efforts are becoming key factors in the opioid use disorder market, as they boost awareness, accessibility, and affordability of addiction treatment globally. These efforts focus on broadening access to treatment and recovery services, improving public health measures, and intensifying law enforcement actions to curb illegal drug availability. They also stress the importance of education and awareness campaigns to avert substance misuse and encourage safe prescribing practices among healthcare professionals. Additionally, these initiatives involve enhancing collaboration among federal, state, and local authorities and integrating evidence-based approaches to tackle the multifaceted issues of opioid addiction in communities nationwide. For instance, in February 2023, in response to the ongoing opioid overdose crisis, the FDA outlined a comprehensive strategy. This includes implementing recommendations from the 2017 NASEM Report, enhancing transparency in opioid analgesic decision-making, and seeking additional congressional authorities. The FDA's Overdose Prevention Framework emphasizes evidence generation through initiatives such as the SOURCE simulation model and advisory committee meetings to evaluate long-term opioid efficacy. In June 2024, an NIH-funded survey revealed significant public unawareness regarding primary care physicians' ability to prescribe medications for OUD, with 61% unaware and 13% holding incorrect beliefs. Targeted campaigns and integrating OUD treatment into primary care settings are recommended to bridge this knowledge gap and improve access to lifesaving medications. The survey suggests a potential market opportunity for pharmaceutical companies and healthcare providers to enhance education & integration efforts, thereby increasing demand for OUD treatments in primary care settings. Opioid Use Disorder Market Report Scope
Moreover, with recent developments and funding allocations, the OUD market is poised for significant shifts, driven by both governmental initiatives and emerging public health insights. For instance, on International Overdose Awareness Day in August 2023, the Biden-Harris administration announced over USD 450 million to combat the overdose epidemic, enhance prevention, treatment, and recovery services, and curb illicit drug trafficking. Initiatives include expanding CDC's OD2A grants, funding drug-free communities, and supporting rural communities with naloxone distribution & behavioral healthcare access. List of Key Players of Opioid Use Disorder Market
Like it? Share it! More by this author |